|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||250.78 - 255.01|
|52 Week Range||210.94 - 321.70|
|Beta (3Y Monthly)||0.85|
|PE Ratio (TTM)||63.81|
|Earnings Date||Feb 28, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||297.50|
Even though biotech markets are “down big this year,” Managing Director Mitchell Ng of Thessalus Capital says that there are “specific industries within the healthcare sector that are very promising,” such as gene editing companies. Yahoo Finance’s Alexis Christoforous speaks to him about the future for biotech in 2019.
NEW YORK, Feb. 11, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
ICU Medical Inc NASDAQ/NGS:ICUIView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for ICUI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding ICUI totaled $2.50 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
SAN CLEMENTE, Calif., Feb. 07, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Building up an investment case requires looking Read More...
Today we are going to look at ICU Medical, Inc. (NASDAQ:ICUI) to see whether it might be an attractive investment prospect. Specifically, we're going to calculate its Return On Capital Read More...
SAN CLEMENTE, Calif., Dec. 27, 2018 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
How far off is ICU Medical, Inc. (NASDAQ:ICUI) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is Read More...
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Carl Icahn and George Soros think. Those hedge fund operators make billions of dollars each […]
Smiths Medical, which has 8,050 employees, has been hit by delays in product launches, a loss of certifications under new regulations and two contract cancellations in the United States. Investors welcomed the move with shares in Smiths Group rising more than 7 percent to 1,411 pence. Chief Executive Andy Reynolds said on a call that all options were being considered for the medical unit, which analysts said could either be sold or separately listed.
The separation will enable the British engineering group to focus on growing as an industrial technology firm, it said on Wednesday. "Following our focus on operational improvements and increased investment, we believe it is now time to prepare the separation of Smiths Medical from the rest of the group," Chief Executive of Smiths, Andy Reynolds, said in a statement. Smiths Medical has been struggling of late, after being hit by delays in new product launches, some products losing certifications under new regulation and the loss of two contracts in the United States.
The San Clemente, California-based company said it had profit of 1 cent per share. Earnings, adjusted for non-recurring costs and stock option expense, were $1.85 per share. The medical device maker posted ...
ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Mid-caps stocks, like ICU Medical Inc (NASDAQ:ICUI) with a market capitalization of US$5.2b, aren’t the focus of most investors who prefer to direct their investments towards either large-cap or small-cap Read More...